Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...51525354555657585960...
CompanyDrug NameStatusIndication Group
Barrier Therapeutics Azoline accomplished Phase IIDermatologicals
Myriad Genetics Azixa in Phase IIAntineoplastic & immunomodulating agents
Myriad Genetics Azixa in Phase IIAntineoplastic & immunomodulating agents
Molecular Insight Azedra in Phase IINervous system
InSite Vision AzaSite plus accomplished Phase IAnti-infectives for systemic use
InSite Vision AzaSite Approved in USAAnti-infectives for systemic use
Regeneron Axokine in Phase IIIAlimentary tract & metabolism
Biogen Idec Avonex in Phase IINervous system
Genzyme Avonex Approved in JapanNervous system
Biogen Idec Avonex Approved in USANervous system
Biogen Idec Avonex Approved in USANervous system
Biogen Idec Avonex accomplished Phase IIINervous system
GlaxoSmithKline Avodart Approved in USAAntineoplastic & immunomodulating agents
GlaxoSmithKline Avodart in Phase IIIAntineoplastic & immunomodulating agents
SuperGen Avicine in Phase IIAntineoplastic & immunomodulating agents
Bayer Avelox Approved in USAAnti-infectives for systemic use
Bayer Avelox Approved in USA and JapanAnti-infectives for systemic use
Genentech Avastin and Tarceva in Phase IIIAntineoplastic & immunomodulating agents
Genentech AVASTIN discontinuedAntineoplastic & immunomodulating agents
Genentech AVASTIN discontinuedAntineoplastic & immunomodulating agents
...51525354555657585960...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.